Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16582-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- AGL antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated AGL antibody (Cat. #16582-1-AP) is a rabbit polyclonal antibody that shows reactivity with mouse, human, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A novel genetic model provides a unique perspective on the relationship between postexercise glycogen concentration and increases in the abundance of key metabolic proteins after acute exercise.
Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver.
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III.
Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III.
MYCT1 alters the glycogen shunt by regulating selective translation of RACK1-mediated enzymes.
Liver fibrosis alters the molecular structures of hepatic glycogen.
Kwak SE, Zheng A, Arias EB, Wang H, Pan X, Yue Y, Duan D, Cartee GD
PloS one 2024;19(1):e0295964
PloS one 2024;19(1):e0295964
Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver.
Jauze L, Vie M, Miagoux Q, Rossiaud L, Vidal P, Montalvo-Romeral V, Saliba H, Jarrige M, Polveche H, Nozi J, Le Brun PR, Bocchialini L, Francois A, Cosette J, Rouillon J, Collaud F, Bordier F, Bertil-Froidevaux E, Georger C, van Wittenberghe L, Miranda A, Daniele NF, Gross DA, Hoch L, Nissan X, Ronzitti G
JCI insight 2024 May 16;9(11)
JCI insight 2024 May 16;9(11)
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III.
Gardin A, Rouillon J, Montalvo-Romeral V, Rossiaud L, Vidal P, Launay R, Vie M, Krimi Benchekroun Y, Cosette J, Bertin B, La Bella T, Dubreuil G, Nozi J, Jauze L, Fragnoud R, Daniele N, Van Wittenberghe L, Esque J, André I, Nissan X, Hoch L, Ronzitti G
The Journal of clinical investigation 2024 Jan 16;134(2)
The Journal of clinical investigation 2024 Jan 16;134(2)
Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III.
Rossiaud L, Pellier E, Benabides M, Nissan X, Ronzitti G, Hoch L
Stem cell research 2023 Oct;72:103214
Stem cell research 2023 Oct;72:103214
MYCT1 alters the glycogen shunt by regulating selective translation of RACK1-mediated enzymes.
Ding DX, Wang Y, Yan W, Fu WN
iScience 2022 Mar 18;25(3):103955
iScience 2022 Mar 18;25(3):103955
Liver fibrosis alters the molecular structures of hepatic glycogen.
Wan Y, Hu Z, Liu Q, Wang L, Sullivan MA, Gilbert RG
Carbohydrate polymers 2022 Feb 15;278:118991
Carbohydrate polymers 2022 Feb 15;278:118991
No comments: Submit comment
No validations: Submit validation data